Answer · confidence: thin
Do EU and US agencies use the same rat and urine tests for saccharin?
Research question: How do EFSA opinions on saccharin, aspartame, and synthetic food dyes rely on the same rodent and urine-chemistry evidence that FDA used in its saccharin and aminotriazole decisions?
The records describe the rat urine-chemistry explanation for removing saccharin warning labels in 2000, which rested on the finding that rodents have high pH, high calcium phosphate, and high protein urine unlike humans 1. They also show that the National Toxicology Program dropped saccharin from its carcinogen list in 2000, which preceded the FDA's 2001 reversal 4. The 1980s and 1990s rat bladder studies behind this history found that saccharin caused tumors only after an initiating agent or at the highest dose 87. For EFSA, the only fact is a 2011 statement that its aspartame panel would have started a re-evaluation had any evidence prompted one 11. None of the facts address EFSA opinions on saccharin or synthetic food dyes, or FDA's aminotriazole decision, so the question cannot be fully answered from them. The newest fact is from 2011, about 15 years before October 2026.
Checked 2026-10-21. Only documented and supported facts are used.
Dig deeper on this questionSources
[1] supported
In 2000 the saccharin warning labels were removed because scientists found that rodents, unlike humans, have a unique urine chemistry of high pH, high calcium phosphate, and high protein.
"However, in 2000, the warning labels were removed because scientists learned that rodents, unlike humans, have a unique combination of high pH, high calcium phosphate , and high protein levels in their urine."Saccharin
[2] supported
Proteins common in male rats combined with calcium phosphate and saccharin to form microcrystals that damaged the bladder lining, which led to tumor formation that does not occur in humans.
"One or more of the proteins that are more prevalent in male rats combine with calcium phosphate and saccharin to produce microcrystals that damage the lining of the bladder."Saccharin
[3] supported
In the 1970s, laboratory rat studies linked high-dose saccharin consumption to bladder cancer.
"In the 1970s, studies performed on laboratory rats found an association between consumption of high doses of saccharin and the development of bladder cancer ."Saccharin
[4] supported
The FDA's 2001 reversal followed a 2000 decision by the National Toxicology Program to remove saccharin from its list of carcinogens.
"The FDA's decision followed a 2000 determination by the U.S. Department of Health and Human Services ' National Toxicology Program to remove saccharin from its list of carcinogens."Saccharin
[5] documented
In the rat bladder study, sodium saccharin was used as a promoter of bladder tumors after the chemical FANFT had been used as an initiator.
"we have used N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide (FANFT) as initiator and sodium saccharin (SAC) or tryptophan as promoters."Multistage carcinogenesis in the urinary bladder. (1983)
[6] supported
In rats, sodium saccharin acts as a bladder carcinogen when given after bladder ulceration, even without a prior initiating agent.
"For example, if sodium saccharin is administered to rats after ulceration of the bladder, even without prior administration of an initiator, bladder carcinoma develops."Promotion in urinary bladder carcinogenesis. (1983)
[7] documented
Light microscopy and labeling-index changes in the rat bladder appeared only at the highest saccharin dose (7.5%), not at the lower doses.
"Light microscopic changes and an increase in labeling index were seen at all time points in rats fed 7.5% sodium saccharin, but not at the lower doses."Comparative analysis of the proliferative response of the rat urinary bladder to sodium saccharin by light and scanning electron microscopy and autoradiography. (1990)
[8] documented
Saccharin did not produce bladder tumors on its own in these experiments; tumors appeared only when it followed FANFT initiation.
"no tumors resulted if either promoter was given without initiation with FANFT."Multistage carcinogenesis in the urinary bladder. (1983)
[9] documented
Dietary sodium saccharin is identified as a promoter in a multistage bladder carcinogenesis process in rats, with MNU or FANFT used as initiators.
"In addition, a multistage carcinogenesis process has been demonstrated for the rat bladder using MNU or FANFT as initiators, and dietary sodium saccharin, sodium cyclamate, or tryptophan as promoters."Promotion in urinary bladder carcinogenesis. (1983)
[10] documented
The rat urothelial hyperplastic response to sodium saccharin varied with both dose and time, and scanning electron microscopy was the most sensitive detection method of the three tested.
"This study demonstrates that the hyperplastic response of the urothelium to sodium saccharin administration varies with dose and time, and that observation by scanning electron microscopy is the most sensitive of the three methods evaluated for detecting these changes."Comparative analysis of the proliferative response of the rat urinary bladder to sodium saccharin by light and scanning electron microscopy and autoradiography. (1990)
[11] documented
EFSA said a re-evaluation of aspartame would have been started immediately if any evidence had led its expert Panel to reconsider the sweetener's safety.
"Had any evidence been found that would have led EFSA’s expert Panel to reconsider the safety of aspartame, a re-evaluation would have been immediately initiated."www.efsa.europa.eu
[12] documented
Saccharin induced bladder tumors even without prior FANFT initiation when the bladder lining was rapidly proliferating from ulceration, pellet insertion, or in utero exposure.
"administration of SAC to animals with a rapidly proliferating bladder mucosa, induced by ulceration, pellet insertion, or in utero, resulted in bladder tumor induction, even without prior initiation with FANFT."Multistage carcinogenesis in the urinary bladder. (1983)